At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.

Management of patients with ovarian cancer in the COVID-19 era

Bogani G.;Casarin J.;Pinelli C.;Brusadelli C.;Guerrisi R.;Ghezzi F.;
2020-01-01

Abstract

At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.
chemotherapy; COVID-19; ovarian cancer; SARS-CoV; surgery; Betacoronavirus; Coronavirus Infections; Female; Gynecologic Surgical Procedures; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Laparoscopy; Ovarian Neoplasms; Pandemics; Pneumonia, Viral; Surgical Oncology
Bogani, G.; Casarin, J.; Pinelli, C.; Di Donato, V.; Bosio, S.; Ruisi, S.; Brusadelli, C.; Guerrisi, R.; Sarpietro, G.; Ditto, A.; Ghezzi, F.; Raspagliesi, F.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2100174
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 7
social impact